control group (n = 30) | Dexmedetomidine group (n = 30) | p | |
---|---|---|---|
Age (years) | 58 ± 8 | 56 ± 8 | 0.533 |
Weight (kg) | 67 ± 7 | 68 ± 8 | 0.562 |
Height (cm) | 167 ± 7 | 168 ± 7 | 0.551 |
Body mass index (kg.m2) | 24 ± 1 | 24 ± 1 | 0.642 |
Sex (male/female) | 4/16 | 15/15 | 0.796 |
ASA physical status (I/II) | 5/25 | 2/28 | 0.421 |
Length of anesthesia (min) | 137 ± 50 | 142 ± 47 | 0.638 |
Intraoperative sufentanil consumption (mcg) | 70 ± 20 | 73 ± 24 | 0.535 |
Type of surgery (n) | |||
Esophageal neoplasia resection | 16 | 17 | 0.795 |
Lobectomy | 6 | 7 | 0.754 |
Pneumonectomy | 1 | 2 | 1.000 |
Mediastinal mass | 2 | 2 | NA |
Pneumothorax | 5 | 2 | 0.421 |
Extubated in operating room (number of patients) | 21 | 1 | 0.584 |